Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects

Schizophrenia Research

Volumn 124, Issue 1-3, 2010, Pages 176-182

  Pietrzak, Robert H ^a,b   Snyder, Peter J ^c,d   Maruff, Paul ^b,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CogState Ltd ^*  (Australia)

^c BROWN UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amphetamine; Cognition; Executive function; Schizophrenia

Indexed keywords

AMPHETAMINE; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MAZE TEST; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; TASK PERFORMANCE; TREATMENT RESPONSE;

ADULT; AMPHETAMINE; CHRONIC DISEASE; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MAZE LEARNING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PRACTICE (PSYCHOLOGY); PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 78249242736     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.09.012     Document Type: Article

References (41)

1. Alvarez J.A., Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol. Rev. 2006, 16:17-42.
2. Barch D.M., Carter C.S. Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. Schizophr. Res. 2005, 77:43-58.
3. Basso M.R., Bornstein R.A., Lang J.M. Practice effects on commonly used measures of executive function across twelve months. Clin. Neuropsychol. 1999, 13:283-292.
4. Basso M.R., Lowery N., Ghormley C., Bornstein R.A. Practice effects on the Wisconsin Card Sorting Test-64 Card version across 12months. Clin. Neuropsychol. 2001, 15:471-478.
5. Basso M.R., Carona F.D., Lowery N., Axelrod B.N. Practice effects on the WAIS-III across 3- and 6-month intervals. Clin. Neuropsychol. 2002, 16:57-63.
6. Bird C.M., Papadopoulou K., Ricciardelli P., Rossor M.N., Cipolotti L. Monitoring cognitive changes: psychometric properties of six cognitive tests. Br. J. Clin. Psychol. 2004, 43:197-210.
7. Braver T.S., Barch D.M., Cohen J.D. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol. Psychiatry 1999, 46:312-328.
8. Breitenstein C., Wailke S., Bushuven S., Kamping S., Zwitserlood P., Ringelstein E.B., Knecht S. d-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology 2004, 29:1704-1714.
9. Buchanan R.W., Keefe R.S., Umbricht D., Green M.F., Laughren T., Marder S.R. The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: what do we know 5 years later?. Schizophr. Bull. 2010.
10. Buck K.K., Atkinson T.M., Ryan J.P. Evidence of practice effects in variants of the Trail Making Test during serial assessment. J. Clin. Exp. Neuropsychol. 2008, 30:312-318.
11. Ceaser A.E., Goldberg T.E., Egan M.F., McMahon R.P., Weinberger D.R., Gold J.M. Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype?. Biol. Psychiatry 2008, 64:782-788.
12. Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd edition) 1988, Erlbaum, Hillsdale, NJ.
13. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., Bigelow L.B., Goldberg T.E., Berman K.F., Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 1991, 11:1907-1917.
14. de Vries M.H., Ulte C., Zwitserlood P., Szymanski B., Knecht S. Increasing dopamine levels in the brain improves feedback-based procedural learning in healthy participants: an artificial-grammar-learning experiment. Neuropsychologia 2010, 48:3193-3197.
15. Falleti M.G., Maruff P., Collie A., Darby D.G. Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J. Clin. Exp. Neuropsychol. 2006, 28:1095-1112.
16. Fillmore M.T., Kelly T.H., Martin C.A. Effects of d-amphetamine in human models of information processing and inhibitory control. Drug Alcohol Depend. 2005, 77:151-159.
17. Fredrickson A., Snyder P.J., Cromer J., Thomas E., Lewis M., Maruff P. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine. Hum. Psychopharmacol. 2008, 23:425-436.
18. Goldberg T.E., Goldman R.S., Burdick K.E., Malhotra A.K., Lencz T., Patel R.C., Woerner M.G., Schooler N.R., Kane J.M., Robinson D.G. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?. Arch. Gen. Psychiatry 2007, 64:1115-1122.
19. Goldberg T.E., Keefe R.S., Goldman R.S., Robinson D.G., Harvey P.D. Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology 2010, 35:1053-1062.
20. Harvey P.D., Cornblatt B.A. Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. Am. J. Psychiatry 2008, 165:163-165.
21. Hempel A., Giesel F.L., Garcia Caraballo N.M., Amann M., Meyer H., Wustenberg T., Essig M., Schroder J. Plasticity of cortical activation related to working memory during training. Am. J. Psychiatry 2004, 161:745-747.
22. Kelly A.M., Garavan H. Human functional neuroimaging of brain changes associated with practice. Cereb. Cortex 2005, 15:1089-1102.
23. Knecht S., Breitenstein C., Bushuven S., Wailke S., Kamping S., Floel A., Zwitserlood P., Ringelstein E.B. Levodopa: faster and better word learning in normal humans. Ann. Neurol. 2004, 56:20-26.
24. Landau S.M., Schumacher E.H., Garavan H., Druzgal T.J., D'Esposito M. A functional MRI study of the influence of practice on component processes of working memory. Neuroimage 2004, 22:211-221.
25. Lencz T., Bilder R.M., Turkel E., Goldman R.S., Robinson D., Kane J.M., Lieberman J.A. Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia. Arch. Gen. Psychiatry 2003, 60:238-243.
26. Petersen S.E., van Mier H., Fiez J.A., Raichle M.E. The effects of practice on the functional anatomy of task performance. Proc. Natl Acad. Sci. USA 1998, 95:853-860.
27. Pietrzak R.H., Cohen H., Snyder P.J. Spatial learning efficiency and error monitoring in normal aging: an investigation using a novel hidden maze learning test. Arch. Clin. Neuropsychol. 2007, 22:235-245.
28. Pietrzak R.H., Maruff P., Mayes L.C., Roman S.A., Sosa J.A., Snyder P.J. An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring. Arch. Clin. Neuropsychol. 2008, 23:433-445.
29. Pietrzak R.H., Maruff P., Snyder P.J. Convergent validity and effect of instruction modification on the groton maze learning test: a new measure of spatial working memory and error monitoring. Int. J. Neurosci. 2009, 119:1137-1149.
30. Pietrzak R.H., Maruff P., Snyder P.J. Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil. J. Nutr. Health Aging 2009, 13:268-273.
31. Pietrzak R.H., Olver J., Norman T., Piskulic D., Maruff P., Snyder P.J. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J. Clin. Exp. Neuropsychol. 2009, 31:848-859.
32. Pietrzak R.H., Snyder P.J., Jackson C.E., Olver J., Norman T., Piskulic D., Maruff P. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals. Hum. Psychopharmacol. 2009, 24:113-121.
33. Pietrzak R.H., Snyder P.J., Maruff P. Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. Hum. Psychopharmacol. 2010, 25:353-358.
34. Snyder A.M., Maruff P., Pietrzak R.H., Cromer J.R., Snyder P.J. Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol. 2008, 14:211-226.
35. Snyder P.J., Jackson C.E., Piskulic D., Olver J., Norman T., Maruff P. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Psychiatry Res. 2008, 160:316-326.
36. Tanaka S. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective. Neuroscience 2006, 139:153-171.
37. Thomas E., Snyder P.J., Pietrzak R.H., Jackson C.E., Bednar M., Maruff P. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Neuropsychologia 2008, 46:2476-2484.
38. Toone B.K., Okocha C.I., Sivakumar K., Syed G.M. Changes in regional cerebral blood flow due to cognitive activation among patients with schizophrenia. Br. J. Psychiatry 2000, 177:222-228.
39. Wexler B.E., Stevens A.A., Bowers A.A., Sernyak M.J., Goldman-Rakic P.S. Word and tone working memory deficits in schizophrenia. Arch. Gen. Psychiatry 1998, 55:1093-1096.
40. Whiting E., Chenery H., Chalk J., Darnell R., Copland D. Dexamphetamine enhances explicit new word learning for novel objects. Int. J. Neuropsychopharmacol. 2007, 10:805-816.
41. Whiting E., Chenery H.J., Chalk J., Darnell R., Copland D.A. The explicit learning of new names for known objects is improved by dexamphetamine. Brain Lang. 2008, 104:254-261.